Literature DB >> 14629904

Neuroprotective effects of early antiretrovirals in vertical HIV infection.

Silvia Sánchez-Ramón1, Salvador Resino, José M Bellón Cano, José T Ramos, Dolores Gurbindo, Angeles Muñoz-Fernández.   

Abstract

We performed a retrospective study of a series of 58 of 189 vertically HIV-1 infected children who went on to develop progressive HIV-1-associated encephalopathy to assess real-life effects of early antiretroviral therapy on neurologic outcome. Our findings clearly indicate that antiretroviral therapy before the onset of neurologic symptoms delayed presentation of progressive HIV-1-associated encephalopathy, with an additional beneficial effect on survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629904     DOI: 10.1016/s0887-8994(03)00210-8

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease.

Authors:  Savvas Andronikou; Christelle Ackermann; Barbara Laughton; Mark Cotton; Nicollette Tomazos; Bruce Spottiswoode; Katya Mauff; John M Pettifor
Journal:  Childs Nerv Syst       Date:  2014-05-23       Impact factor: 1.475

2.  Corpus callosum thickness on mid-sagittal MRI as a marker of brain volume: a pilot study in children with HIV-related brain disease and controls.

Authors:  Savvas Andronikou; Christelle Ackermann; Barbara Laughton; Mark Cotton; Nicollette Tomazos; Bruce Spottiswoode; Katya Mauff; John M Pettifor
Journal:  Pediatr Radiol       Date:  2015-01-27

3.  Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection.

Authors:  J Rutstein Lazarus; R M Rutstein; E D Lowenthal
Journal:  HIV Med       Date:  2015-01-21       Impact factor: 3.180

4.  Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.

Authors:  Kunjal Patel; Xue Ming; Paige L Williams; Kevin R Robertson; James M Oleske; George R Seage
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

5.  Neurodevelopmental assessment of HIV-exposed uninfected and early-treated HIV-infected children: study protocol.

Authors:  Renate Strehlau; Tamryn van Aswegen; Joanne Potterton
Journal:  BMC Res Notes       Date:  2018-04-06

6.  Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy.

Authors:  Lotus A van Arnhem; Madeleine J Bunders; Henriette J Scherpbier; Charles B L M Majoie; Liesbeth Reneman; Olivier Frinking; Bwee Tien Poll-The; Taco W Kuijpers; Dasja Pajkrt
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

7.  Dominican Children with HIV not Receiving Antiretrovirals: Massage Therapy Influences their Behavior and Development.

Authors:  Maria Hernandez-Reif; Gail Shor-Posner; Jeannette Baez; Solange Soto; Rosangela Mendoza; Raquel Castillo; Noaris Quintero; Eddy Perez; Guoyan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.